Department of Biochemistry and Molecular Genetics, College of Medicine, University of Illinois at Chicago, Chicago, Ill.
Department of Biology and Biochemistry, University of Bath, Bath, United Kingdom.
J Allergy Clin Immunol. 2020 Aug;146(2):377-389.e10. doi: 10.1016/j.jaci.2020.01.013. Epub 2020 Jan 23.
The human eosinophil Charcot-Leyden crystal (CLC) protein is a member of the Galectin superfamily and is also known as galectin-10 (Gal-10). CLC/Gal-10 forms the distinctive hexagonal bipyramidal crystals that are considered hallmarks of eosinophil participation in allergic responses and related inflammatory reactions; however, the glycan-containing ligands of CLC/Gal-10, its cellular function(s), and its role(s) in allergic diseases are unknown.
We sought to determine the binding partners of CLC/Gal-10 and elucidate its role in eosinophil biology.
Intracellular binding partners were determined by ligand blotting with CLC/Gal-10, followed by coimmunoprecipitation and coaffinity purifications. The role of CLC/Gal-10 in eosinophil function was determined by using enzyme activity assays, confocal microscopy, and short hairpin RNA knockout of CLC/Gal-10 expression in human CD34 cord blood hematopoietic progenitors differentiated to eosinophils.
CLC/Gal-10 interacts with both human eosinophil granule cationic ribonucleases (RNases), namely, eosinophil-derived neurotoxin (RNS2) and eosinophil cationic protein (RNS3), and with murine eosinophil-associated RNases. The interaction is independent of glycosylation and is not inhibitory toward endoRNase activity. Activation of eosinophils with INF-γ induces the rapid colocalization of CLC/Gal-10 with eosinophil-derived neurotoxin/RNS2 and CD63. Short hairpin RNA knockdown of CLC/Gal-10 in human cord blood-derived CD34 progenitor cells impairs eosinophil granulogenesis.
CLC/Gal-10 functions as a carrier for the sequestration and vesicular transport of the potent eosinophil granule cationic RNases during both differentiation and degranulation, enabling their intracellular packaging and extracellular functions in allergic inflammation.
人类嗜酸性粒细胞夏科-莱登晶体(CLC)蛋白是半乳糖凝集素超家族的成员,也被称为半乳糖凝集素-10(Gal-10)。CLC/Gal-10 形成独特的六方双锥晶体,被认为是嗜酸性粒细胞参与过敏反应和相关炎症反应的标志;然而,CLC/Gal-10 的糖结合配体、其细胞功能及其在过敏性疾病中的作用尚不清楚。
我们试图确定 CLC/Gal-10 的结合伴侣,并阐明其在嗜酸性粒细胞生物学中的作用。
通过用 CLC/Gal-10 进行配体印迹,然后进行共免疫沉淀和共亲和纯化,确定细胞内结合伴侣。通过使用酶活性测定、共聚焦显微镜和短发夹 RNA 敲除人 CD34 脐带血造血祖细胞分化为嗜酸性粒细胞中的 CLC/Gal-10 表达,来确定 CLC/Gal-10 在嗜酸性粒细胞功能中的作用。
CLC/Gal-10 与两种人类嗜酸性粒细胞颗粒阳离子核糖核酸酶(RNases),即嗜酸性粒细胞衍生的神经毒素(RNS2)和嗜酸性粒细胞阳离子蛋白(RNS3),以及与鼠嗜酸性粒细胞相关的 RNases 相互作用。这种相互作用不依赖于糖基化,并且对内切核糖核酸酶活性没有抑制作用。IFN-γ 激活嗜酸性粒细胞可诱导 CLC/Gal-10 与嗜酸性粒细胞衍生的神经毒素/RNS2 和 CD63 的快速共定位。短发夹 RNA 敲低人脐带血来源的 CD34 祖细胞中的 CLC/Gal-10 可损害嗜酸性粒细胞粒细胞发生。
CLC/Gal-10 作为一种载体,在分化和脱颗粒过程中,将强效的嗜酸性粒细胞颗粒阳离子 RNases 进行隔离和囊泡运输,使其在过敏性炎症中进行细胞内包装和细胞外功能。